Search

Your search keyword '"Gustafson KE"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Gustafson KE" Remove constraint Author: "Gustafson KE"
43 results on '"Gustafson KE"'

Search Results

2. Sexual and gender identities and alcohol use during the COVID-19 pandemic.

3. Subventricular zone stem cell niche injury is associated with intestinal perforation in preterm infants and predicts future motor impairment.

4. Do Bayley-III Composite Scores at 18-22 Months Corrected Age Predict Full-Scale IQ at 6-7 Years in Children Born Extremely Preterm?

5. Emotional support among partnered sexual minority and heterosexual individuals during the COVID-19 pandemic.

6. A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic-Ischemic Encephalopathy.

7. Cortisol awakening response and developmental outcomes at 6-7 years in children born extremely preterm.

8. Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease.

9. Survival, Morbidities, and Developmental Outcomes among Low Birth Weight Infants with Congenital Heart Defects.

10. A Multidisciplinary Patient-Specific Opioid Prescribing and Tapering Protocol Is Associated with a Decrease in Total Opioid Dose Prescribed for Six Weeks After Total Hip Arthroplasty.

11. Genetic variation in dopamine neurotransmission and motor development of infants born extremely-low-birthweight.

12. Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathy.

13. Preterm Neuroimaging and School-Age Cognitive Outcomes.

14. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial.

15. The importance of managing the patient and not the gene: expanded phenotype of GLE1 -associated arthrogryposis.

16. Behavioral Problems and Socioemotional Competence at 18 to 22 Months of Extremely Premature Children.

17. Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability.

18. Thinner Retinal Nerve Fiber Layer in Very Preterm Versus Term Infants and Relationship to Brain Anatomy and Neurodevelopment.

19. FUNCTIONAL OUTCOMES OF YOUNG INFANTS WITH AND WITHOUT MACULAR EDEMA.

20. Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery.

21. Evaluation of optic nerve development in preterm and term infants using handheld spectral-domain optical coherence tomography.

22. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.

23. Perinatal factors associated with poor neurocognitive outcome in early school age congenital diaphragmatic hernia survivors.

24. Effect of antenatal treatment of maternal periodontitis on early childhood neurodevelopment.

25. Childhood outcomes after hypothermia for neonatal encephalopathy.

27. Neurocognitive development of young children with sickle cell disease through three years of age.

28. Illness specific patterns of psychological adjustment and cognitive adaptational processes in children with cystic fibrosis and sickle cell disease.

29. Developmental outcome of very low birth weight infants at four years of age as a function of biological risk and psychosocial risk.

30. Behavioral characteristics of very-low-birth-weight infants of varying biologic risk at 6, 15, and 24 months of age.

32. Screening for child-reported behavioral and emotional problems in primary care pediatrics.

33. Developmental outcome of very low birth weight infants as a function of biological risk and psychosocial risk.

34. Psychological adjustment of children with sickle cell disease: stability and change over a 10-month period.

35. Change over a 12-month period in the psychological adjustment of children and adolescents with cystic fibrosis.

36. Stability and change in the psychological adjustment of mothers of children and adolescents with cystic fibrosis and sickle cell disease.

37. Parents' informed consent decisions regarding psychotherapy for their children: consideration of therapeutic risks and benefits.

38. Nursery neurobiologic risk score: levels of risk and relationships with nonmedical factors.

39. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment.

40. Stress, coping, and family functioning in the psychological adjustment of mothers of children and adolescents with cystic fibrosis.

41. The role of biomedical and psychosocial processes in the intellectual and academic functioning of children and adolescents with cystic fibrosis.

42. Parents' and clinicians' attitudes toward the risks and benefits of child psychotherapy: a study of informed-consent content.

43. Psychological problems associated with drug therapy in childhood asthma.

Catalog

Books, media, physical & digital resources